Pharmaceutical Intermediate Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Applications, and Distribution Channel and Geography

List of Tables

The pharmaceutical intermediate market was valued at US$ 27,356.70 million in 2020 and is projected to reach US$ 37,290.33 million by 2028; it is expected to grow at a CAGR of 4.2% from 2021 to 2028.

The rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities drive the growth of the pharmaceutical intermediate market. However, the high cost of drug manufacturing hinders the market growth.

Pharmaceutical intermediates are the building blocks of active pharmaceutical ingredients (APIs). These are raw materials that undergo molecular change or processing during bulk drug production. Thus, the requirement of pharmaceutical intermediates increases with the rise in demand for drugs to treat chronic diseases. As per the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the US suffer from at least one chronic disease such as cancer, heart disease, lung disease, stroke, neurological disease, diabetes, and kidney diseases. Moreover, 4 in 10 adults in the country have two or more chronic diseases. Additionally, according to the press release by the European Chronic Disease Alliance (ECDA), in 2014, 9 out of 10 people in Europe die due to chronic diseases. Thus, 70-80% of the total healthcare costs are spent on the management of chronic diseases.

The surging prevalence of infectious diseases, especially in Southeast Asia, is also likely to propel the demand for APIs in the coming years, eventually driving the growth of the pharmaceutical intermediate market. For instance, as per the Revised National Tuberculosis Control Programme Report, around 4.4 lakh patients died due to tuberculosis in India in 2018, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is bolstering the demand for drugs, eventually highlighting the need of pharmaceutical intermediates.

Based on type, the pharmaceutical intermediate market is bifurcated into GMP and non GMP counters. In 2020, GMP accounted for a larger share in the market owing to increase in the adoption of good manufacturing practices (GMP) by pharmaceutical companies. These regulations are designed to reduce the risks involved in the production of pharmaceuticals that cannot be eliminated through testing the finished product.

In terms of application, the pharmaceutical intermediate market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, whereas the vitamins segment is estimated to register the highest CAGR in the market during the forecast period.

World Health Organization (WHO), European Chronic Disease Alliance (ECDA), US Food and Drug Administration (FDA), Pharmaceutical Research and Manufacturers Association (PhRMA), US Census Bureau, the Germany Trade & Invest (GTAI), European Medicine Agency (EMA), and Institute for Integrated Economic Research Australia are among the major secondary sources referred to while preparing the report on the pharmaceutical intermediate market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical intermediate market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical intermediate market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Product Code: TIPRE00005559

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Pharmaceutical Intermediates Market - By Type
- 1.3.2 Global Pharmaceutical Intermediates Market - By Application
- 1.3.3 Global Pharmaceutical Intermediates Market - By Distribution Channel
- 1.3.4 Global Pharmaceutical Intermediates Market- By Geography

2. Pharmaceutical Intermediates Market- Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Pharmaceutical Intermediates Market- Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 APAC PEST Analysis
- 4.2.4 MEA PEST Analysis
- 4.2.5 SCAM PEST Analysis
4.3 Expert Opinion

5. Pharmaceutical Intermediates Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases
- 5.1.2 Escalating R&D Investments by Pharmaceutical Companies
5.2 Market Restraints
- 5.2.1 High Cost of Manufacturing
5.3 Market Opportunities
- 5.3.1 Emerging Markets
5.4 Future Trends
- 5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery
5.5 Impact Analysis

6. Pharmaceutical Intermediates Market- Global Analysis

6.1 Global Pharmaceutical Intermediates Market Revenue Forecast and Analysis
6.2 Global Pharmaceutical Intermediates Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Pharmaceutical Intermediates Market Analysis - By Type

7.1 Overview
7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
7.3 GMP
- 7.3.1 Overview
- 7.3.2 GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Non GMP
- 7.4.1 Overview
- 7.4.2 Non GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

8. Pharmaceutical Intermediates Market Analysis - By Application

8.1 Overview
8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
8.3 Antibiotics
- 8.3.1 Overview
- 8.3.2 Antibiotics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Antipyretic Analgesics
- 8.4.1 Overview
- 8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Vitamins
- 8.5.1 Overview
- 8.5.2 Vitamins: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
8.6 Other
- 8.6.1 Overview
- 8.6.2 Other: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

9. Pharmaceutical Intermediates Market- By Distribution Channel

9.1 Overview
9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
9.3 Distributor
- 9.3.1 Overview
- 9.3.2 Distributor: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Direct Sales
- 9.4.1 Overview
- 9.4.2 Direct Sales: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

10. Pharmaceutical Intermediates Market - Geographical Analysis

10.1 North America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
- 10.1.1 Overview
- 10.1.2 North America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
- 10.1.3 North America: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
- 10.1.4 North America: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
- 10.1.5 North America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.1.6 North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
- 10.1.7 US: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.1.7.1 US: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.1.7.2 US: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.1.7.3 US: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.1.7.4 US: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.1.8 Canada: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.1.8.1 Canada: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.1.8.2 Canada: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.1.8.3 Canada: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.1.8.4 Canada: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.1.9 Mexico: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.1.9.1 Mexico: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.1.9.2 Mexico: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.1.9.3 Mexico: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.1.9.4 Mexico: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
10.2 Europe: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
- 10.2.1 Overview
- 10.2.2 Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
- 10.2.3 Europe: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
- 10.2.4 Europe: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
- 10.2.5 Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.2.6 Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
- 10.2.7 Germany: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.7.1 Germany: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.7.2 Germany: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.2.7.3 Germany: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.2.7.4 Germany: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.2.8 UK: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.8.1 UK: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.8.2 UK: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.2.8.3 UK: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.2.8.4 UK: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.2.9 France: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.9.1 France: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.9.2 France: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.2.9.3 France: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.2.9.4 France: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.2.10 Spain: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.10.1 Spain: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.10.2 Spain: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.2.10.3 Spain: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.2.10.4 Spain: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.2.11 Italy: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.11.1 Italy: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.11.2 Italy: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.2.11.3 Italy: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.2.11.4 Italy: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.2.12 Rest of Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.12.1 Rest of Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.2.12.2 Rest of Europe: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.2.12.3 Rest of Europe: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.2.12.4 Rest of Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
10.3 Asia Pacific: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
- 10.3.3 Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
- 10.3.4 Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
- 10.3.5 Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.3.6 Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
- 10.3.7 China: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.7.1 China: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.7.2 China: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.3.7.3 China: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.3.7.4 China: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.3.8 Japan: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.8.1 Japan: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.8.2 Japan: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.3.8.3 Japan: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.3.8.4 Japan: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.3.9 India: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.9.1 India: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.9.2 India: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.3.9.3 India: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.3.9.4 India: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.3.10 Australia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.10.1 Australia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.10.2 Australia: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.3.10.3 Australia: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.3.10.4 Australia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.3.11 South Korea: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.11.1 South Korea: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.11.2 South Korea: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.3.11.3 South Korea: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.3.11.4 South Korea: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.3.12 Rest of Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.12.1 Rest of Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.3.12.2 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.3.12.3 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.3.12.4 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
10.4 Middle East & Africa: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
- 10.4.1 Overview
- 10.4.2 Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
- 10.4.3 Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
- 10.4.4 Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
- 10.4.5 Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.4.6 Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
- 10.4.7 Saudi Arabia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.7.1 Saudi Arabia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.7.2 Saudi Arabia: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.4.7.3 Saudi Arabia: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.4.7.4 Saudi Arabia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.4.8 UAE: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.8.1 UAE: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.8.2 UAE: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.4.8.3 UAE: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.4.8.4 UAE: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.4.9 South Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.9.1 South Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.9.2 South Africa: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.4.9.3 South Africa: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.4.9.4 South Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.4.10 Rest of Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.10.1 Rest of Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.4.10.2 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.4.10.3 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.4.10.4 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
10.5 South and Central America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
- 10.5.1 South and Central America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
- 10.5.2 South and Central America: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
- 10.5.3 South and Central America: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
- 10.5.4 South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.5.5 South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
- 10.5.6 Brazil: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.5.6.1 Brazil: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.5.6.2 Brazil: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.5.6.3 Brazil: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.5.6.4 Brazil: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.5.7 Argentina: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.5.7.1 Argentina: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.5.7.2 Argentina: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.5.7.3 Argentina: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.5.7.4 Argentina: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
- 10.5.8 Rest of South and Central America: Pharmaceutical Intermediates Market- Revenue and Forecasts to 2027 (USD Million)
  - 10.5.8.1 Rest of South and Central America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  - 10.5.8.2 Rest of South and Central America: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
  - 10.5.8.3 Rest of South and Central America: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
  - 10.5.8.4 Rest of South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Intermediates Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Pharmaceutical Intermediates Market- Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 Pfizer Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Sanofi
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BASF SE
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Lianhe Chemical Technology Co., Ltd.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Dishman Carbogen Amcis Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Codexis
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Midas Pharma GmbH
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 chiracon GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Dextra Laboratories Limited
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Vertellus Holdings LLC
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners
14.2 Glossary of Terms